Harriet Roddy is closing our first session with her presentation on ‘Next Generation Autologous CAR T cells for the treatment of Hepatocellular Carcinoma’ #CRUKCoL2025
What a time to be a woman! @JasminKParis showing us that even the things people thought were impossible are possible. #BM100#smalleuropeanwoman I was truly hooked on a 60 hour race.
Superstar @uclcancer PhD student Vedika Mehra leads this fantastic work on next-gen. AUTO1 CAR-T for leukaemia. Her process generates polyfunctional, Tscm/Tcm-skewed products for patients, towards even better CAR-T outcomes🚨 @jitcancer https://t.co/w65UUJIPqH
Shark tank session at ILCA23 was a great opportunity to see peers present great ideas. Look forward to seeing what they achieve over the next year. It’s a fun format I would love to take part in next time! @ILCAnews#ILCA2023
Great first day at ILCA 2023 Annual Conference!
Lots of exciting work shared. Y-ILCA committee have been great at welcoming the next generation in with interactive and specific sessions.
#ILCA2023@ILCAnews
CR and NR archetypes of CART products can be identified using transcriptomic signatures (exhaustion and differentiation) but not by immunophenotypic analyses
https://t.co/CobtHPTR5j
❗️Another week, another PhD student has come to my office in tears as they can’t afford to live in London on £18k. And this is before the price cap increase. @UKRI_News this time - can I ask what you are doing to support the next-generation so there is a next-generation?! Pls RT
We are excited to share our latest paper where we developed an imaging and computational platform BEHAV3D to uncover the mode of action of engineered T cells in patient #cancer#organoids. Out today in Nature Biotechnology. Check out this thread. #immunotherapy#microscopy
Please RT. PhD students funded by @UKRI_News face a cash crisis. They are working full-time, yet earning less than living wage. With the rising cost of living and increasing pressure to deliver high quality research that benefits society, something needs to change. THREAD (1/10)
New paper alert! A pandemic side project which turned out to be quite exciting, with @Marcrmansour @pa_wawrzyniecka@nicola_maciocia and others. We showed that CCR9 is a potential new CAR-T target for T acute lymphoblastic leukemia (T-ALL). 1/10
https://t.co/n6r2ypLXC2